134 related articles for article (PubMed ID: 31630877)
1. Autoantibodies to mRNA processing pathways (glycine and tryptophan-rich bodies antibodies): prevalence and clinical utility in a South Australian cohort.
Al Kindi M; Cassidy J; Gilham D; Fritzler M; Hissaria P
Pathology; 2019 Dec; 51(7):723-726. PubMed ID: 31630877
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis.
Stinton LM; Swain M; Myers RP; Shaheen AA; Fritzler MJ
Clin Exp Immunol; 2011 Feb; 163(2):147-56. PubMed ID: 21091667
[TBL] [Abstract][Full Text] [Related]
3. Clinical and serological features of patients with autoantibodies to GW/P bodies.
Bhanji RA; Eystathioy T; Chan EK; Bloch DB; Fritzler MJ
Clin Immunol; 2007 Dec; 125(3):247-56. PubMed ID: 17870671
[TBL] [Abstract][Full Text] [Related]
4. Establishment of international autoantibody reference standards for the detection of autoantibodies directed against PML bodies, GW bodies, and NuMA protein.
Zheng B; Mora RA; Fritzler MJ; Satoh M; Bloch DB; Garcia-De La Torre I; Boylan K; Kohl K; Wener MH; Andrade LEC; Chan EKL
Clin Chem Lab Med; 2020 Aug; 59(1):197-207. PubMed ID: 32776893
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of unidentified precipitin lines (UPLs) in immune precipitation assays.
Pajaro A; Nikoloutsopoulos T; Roberts-Thomson P
Pathology; 2015 Jan; 47(1):62-7. PubMed ID: 25474508
[TBL] [Abstract][Full Text] [Related]
6. Anti-ENA profiles related with anti-SS-A/Ro. The detection of Ro52 and Ro60 according to the presence of SS-B/La, and ANA pattern and titer.
González DA; Rodríguez CC; Armas LM; Varela AR; Rodríguez IM; Duarte MT; de León AC
Immunol Lett; 2014 Sep; 161(1):6-12. PubMed ID: 24768604
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ANA testing by indirect immunofluorescence or solid-phase assays in a low pre-test probability population for systemic autoimmune disease: the Camargo Cohort.
Martinez-Revuelta D; Irure-Ventura J; López-Hoyos M; Olmos JM; Pariente E; Martín-Millán M; Nan D; Comins-Boo A; Martínez-Taboada VM; Hernández JL
Clin Chem Lab Med; 2023 May; 61(6):1095-1104. PubMed ID: 36634098
[TBL] [Abstract][Full Text] [Related]
8. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
Broadfoot A; Sivertsen T; Baumgart K
Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
[TBL] [Abstract][Full Text] [Related]
9. Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study.
Infantino M; Palterer B; Biagiotti R; Almerigogna F; Benucci M; Damiani A; Grossi V; Azzurri A; Casprini P; Bacci G; Giudizi MG; Manfredi M
Immunol Res; 2018 Feb; 66(1):74-78. PubMed ID: 29159696
[TBL] [Abstract][Full Text] [Related]
10. [Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases].
Kim JM; Ihm CH; Sin DH; Ihm MK; Sim SC
Korean J Lab Med; 2008 Oct; 28(5):353-61. PubMed ID: 18971616
[TBL] [Abstract][Full Text] [Related]
11. Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.
Amlani A; Choi MY; Tarnopolsky M; Brady L; Clarke AE; Garcia-De La Torre I; Mahler M; Schmeling H; Barber CE; Jung M; Fritzler MJ
Front Immunol; 2019; 10():745. PubMed ID: 31024569
[No Abstract] [Full Text] [Related]
12. Practical evaluation of methods for detection and specificity of autoantibodies to extractable nuclear antigens.
Orton SM; Peace-Brewer A; Schmitz JL; Freeman K; Miller WC; Folds JD
Clin Diagn Lab Immunol; 2004 Mar; 11(2):297-301. PubMed ID: 15013979
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens.
Almeida González D; Cabrera de León A; Rodríguez Pérez Mdel C; Brito Díaz B; González Hernández A; García García D; Vázquez Moncholi C; Aguirre Jaime A
J Immunol Methods; 2010 Aug; 360(1-2):89-95. PubMed ID: 20600078
[TBL] [Abstract][Full Text] [Related]
14. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
Desplat-Jego S; Bardin N; Larida B; Sanmarco M
Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
[TBL] [Abstract][Full Text] [Related]
16. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.
Murng SHK; Thomas M
J Clin Pathol; 2018 Jan; 71(1):12-19. PubMed ID: 28663326
[TBL] [Abstract][Full Text] [Related]
17. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies.
Kang I; Siperstein R; Quan T; Breitenstein ML
Clin Rheumatol; 2004 Dec; 23(6):509-15. PubMed ID: 15801070
[TBL] [Abstract][Full Text] [Related]
18. Anti-DFS70 antibodies detected by immunoblot methods: A reliable tool to confirm the dense fine speckles ANA pattern.
Bizzaro N; Pesente F; Cucchiaro F; Infantino M; Tampoia M; Villalta D; Fabris M; Tonutti E
J Immunol Methods; 2016 Sep; 436():50-3. PubMed ID: 27374867
[TBL] [Abstract][Full Text] [Related]
19. From ANA to ENA: how to proceed?
Damoiseaux JG; Tervaert JW
Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206
[TBL] [Abstract][Full Text] [Related]
20. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
Peene I; Meheus L; Veys EM; De Keyser F
Ann Rheum Dis; 2001 Dec; 60(12):1131-6. PubMed ID: 11709455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]